PARSOLEX GMP CENTER
Dead / Abandoned — Abandoned — no statement of use filed (as of 22 Feb 2021)
What this means for you
This application is over — abandoned 22 Feb 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88537072
- Mark type
- Stylized text
- Filed
- 25 Jul 2019
- Published for opposition
- 26 May 2020
- Abandoned
- 22 Feb 2021
- Attorney of record
- Jill J. Chalmers
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of infectious diseases, deficiency diseases, genetic and hereditary diseases, neurological diseases, and physiological diseases manufactured using the Current Good Manufacturing Practice regulations enforced by the FDA; a full line of pharmaceuticals and medicines manufactured using the Current Good Manufacturing Practice regulations enforced by the FDA
Owner
- Parsolex GMP Center, Inc., West Lafayette, IN, US
- Parsolex GMP Center, Inc., West Lafayette, IN, US
Prosecution history
- 22 Feb 2021 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 Feb 2021 — ABANDONMENT - NO USE STATEMENT FILED
- 21 Jul 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 May 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 May 2020 — PUBLISHED FOR OPPOSITION
- 06 May 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Apr 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Apr 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Apr 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Apr 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 31 Oct 2019 — NOTIFICATION OF PRIORITY ACTION E-MAILED
- 31 Oct 2019 — PRIORITY ACTION E-MAILED
- 31 Oct 2019 — PRIORITY ACTION WRITTEN
- 16 Oct 2019 — ASSIGNED TO EXAMINER
- 02 Aug 2019 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED